These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35878320)

  • 1. When Will Fondaparinux Induce Thrombocytopenia?
    Chen LY; Khan N; Lindenbauer A; Nguyen TH
    Bioconjug Chem; 2022 Aug; 33(8):1574-1583. PubMed ID: 35878320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.
    Krauel K; Fürll B; Warkentin TE; Weitschies W; Kohlmann T; Sheppard JI; Greinacher A
    J Thromb Haemost; 2008 Dec; 6(12):2160-7. PubMed ID: 18983520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
    Seculini Patiño CE; Pascualini MF; Tabares AH
    Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomic description of the immune complex involved in heparin-induced thrombocytopenia.
    Cai Z; Yarovoi SV; Zhu Z; Rauova L; Hayes V; Lebedeva T; Liu Q; Poncz M; Arepally G; Cines DB; Greene MI
    Nat Commun; 2015 Sep; 6():8277. PubMed ID: 26391892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fondaparinux: does it cause HIT? Can it treat HIT?
    Warkentin TE
    Expert Rev Hematol; 2010 Oct; 3(5):567-81. PubMed ID: 21083474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia.
    Warkentin TE
    Thromb Haemost; 2016 Oct; 116(5):813-822. PubMed ID: 27656712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of ultralarge immune complexes in heparin-induced thrombocytopenia.
    Cai Z; Bdeir K; Yarovoi SV; Rauova L; Arepally GM; Khandelwal S; Rollin J; Gruel Y; Zaitsev S; Poncz M; Greene MI; Cines DB
    J Thromb Haemost; 2023 Mar; 21(3):652-666. PubMed ID: 36696211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.
    Warkentin TE; Cook RJ; Marder VJ; Sheppard JA; Moore JC; Eriksson BI; Greinacher A; Kelton JG
    Blood; 2005 Dec; 106(12):3791-6. PubMed ID: 16109780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced Thrombocytopenia.
    Vayne C; Nguyen TH; Rollin J; Charuel N; Poupon A; Pouplard C; Normann N; Gruel Y; Greinacher A
    Thromb Haemost; 2021 Mar; 121(3):322-331. PubMed ID: 33086397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
    Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
    Grouzi E; Kyriakou E; Panagou I; Spiliotopoulou I
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):663-7. PubMed ID: 19825921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.
    Arepally GM; Kamei S; Park KS; Kamei K; Li ZQ; Liu W; Siegel DL; Kisiel W; Cines DB; Poncz M
    Blood; 2000 Mar; 95(5):1533-40. PubMed ID: 10688805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?
    Sarkar A; Khandelwal S; Koma GT; Kim H; Gruel Y; Rollin J; Passam F; Wool GD; Arepally GM; Cines DB; Rauova L; Poncz M
    Blood Adv; 2023 Aug; 7(15):4112-4123. PubMed ID: 37196641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.
    Litvinov RI; Yarovoi SV; Rauova L; Barsegov V; Sachais BS; Rux AH; Hinds JL; Arepally GM; Cines DB; Weisel JW
    J Biol Chem; 2013 Nov; 288(46):33060-70. PubMed ID: 24097975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin.
    Al-Rossaies A; Alkharfy KM; Al-Ayoubi F; Al-Momen A
    Int J Clin Pharm; 2011 Dec; 33(6):997-1001. PubMed ID: 22002684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
    Efird LE; Kockler DR
    Ann Pharmacother; 2006; 40(7-8):1383-7. PubMed ID: 16788093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization.
    Warkentin TE; Cook RJ; Marder VJ; Greinacher A
    J Thromb Haemost; 2010 Mar; 8(3):504-12. PubMed ID: 20050998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Special considerations with fondaparinux therapy: heparin-induced thrombocytopenia and wound healing.
    Dager WE; Andersen J; Nutescu E
    Pharmacotherapy; 2004 Jul; 24(7 Pt 2):88S-94S. PubMed ID: 15317404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia?
    Badger NO
    J Pharm Pract; 2010 Jun; 23(3):235-8. PubMed ID: 21507819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.